CH434571A - Verfahren zur Herstellung von Antibiotika mit verlängerter therapeutischer Wirkung - Google Patents

Verfahren zur Herstellung von Antibiotika mit verlängerter therapeutischer Wirkung

Info

Publication number
CH434571A
CH434571A CH1808365A CH1808365A CH434571A CH 434571 A CH434571 A CH 434571A CH 1808365 A CH1808365 A CH 1808365A CH 1808365 A CH1808365 A CH 1808365A CH 434571 A CH434571 A CH 434571A
Authority
CH
Switzerland
Prior art keywords
antibiotics
manufacture
therapeutic effects
prolonged therapeutic
prolonged
Prior art date
Application number
CH1808365A
Other languages
English (en)
Inventor
E Corn Murray
Original Assignee
Chemical And Pharmaceutical Pa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemical And Pharmaceutical Pa filed Critical Chemical And Pharmaceutical Pa
Priority to ES335038A priority Critical patent/ES335038A1/es
Publication of CH434571A publication Critical patent/CH434571A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CH1808365A 1965-12-30 1965-12-30 Verfahren zur Herstellung von Antibiotika mit verlängerter therapeutischer Wirkung CH434571A (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES335038A ES335038A1 (es) 1965-12-30 1966-12-28 Procedimiento para la produccion de una preparacion farma- ceutica teniendo actividad farmaceutica sostenida.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56251666A 1966-07-05 1966-07-05

Publications (1)

Publication Number Publication Date
CH434571A true CH434571A (de) 1967-04-30

Family

ID=24246598

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1808365A CH434571A (de) 1965-12-30 1965-12-30 Verfahren zur Herstellung von Antibiotika mit verlängerter therapeutischer Wirkung

Country Status (4)

Country Link
US (1) US3499959A (de)
CH (1) CH434571A (de)
GB (1) GB1245467A (de)
NL (1) NL6702415A (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344934A (en) * 1978-11-20 1982-08-17 American Home Products Corporation Therapeutic compositions with enhanced bioavailability
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds
EP0327295A3 (de) * 1988-02-01 1989-09-06 F.H. FAULDING & CO. LTD. Tetracyclin-Dosisform
AU614328B2 (en) * 1988-02-01 1991-08-29 Mayne Pharma International Pty Ltd Tetracycline dosage form
US5277916A (en) * 1988-02-01 1994-01-11 F. H. Faulding & Co., Ltd. Tetracycline dosage form
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5122384A (en) * 1989-05-05 1992-06-16 Kv Pharmaceutical Company Oral once-per-day organic nitrate formulation which does not induce tolerance
ATE114472T1 (de) * 1989-09-21 1994-12-15 American Cyanamid Co System des typs ''einmal täglich'' zur gepulsten minocyclinabgabe.
JP2535141B2 (ja) * 1995-01-17 1996-09-18 中外製薬株式会社 フマル酸含有徐放性製剤
TWI225402B (en) * 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
CA2936748C (en) 2014-10-31 2017-08-08 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2953497A (en) * 1953-06-03 1960-09-20 Howard A Press Therapeutic tablets
US2809916A (en) * 1955-10-17 1957-10-15 Victor M Hermelin Sustained release pharmaceutical preparations
NL109170C (de) * 1958-02-03
US2971889A (en) * 1958-03-18 1961-02-14 Smith Kline French Lab Press coated enteric tablets and process for preparing them
US2954322A (en) * 1958-09-04 1960-09-27 Olin Mathieson Pharmaceuticals
US2928770A (en) * 1958-11-28 1960-03-15 Frank M Bardani Sustained action pill

Also Published As

Publication number Publication date
US3499959A (en) 1970-03-10
NL6702415A (de) 1968-08-19
GB1245467A (en) 1971-09-08

Similar Documents

Publication Publication Date Title
CH434571A (de) Verfahren zur Herstellung von Antibiotika mit verlängerter therapeutischer Wirkung
CH469011A (de) Verfahren zur Herstellung von Pyrazinimidoylguanidinen
CH466279A (de) Verfahren zur Herstellung von 2-Amino-3-pyridinol
CH476746A (de) Verfahren zur Herstellung von Chlor-diamino-s-triazinen
AT262251B (de) Verfahren zur Herstellung von N-Acylvinylaminen
CH469655A (de) Verfahren zur Herstellung von a-Methyl-pentacycloalkanmethylaminen
AT262258B (de) Verfahren zur Herstellung von Aminokresolen
CH470408A (de) Verfahren zur Herstellung von Aminoisoxazolen
CH457665A (de) Verfahren zur Herstellung von 1-Amino-2-hydroxyalkoxy-4-hydroxyanthrachinonen
CH471787A (de) Verfahren zur Herstellung von Pyridyldihydroisochinolinen
CH472392A (de) Verfahren zur Herstellung von Betamercaptopropionitril
CH460019A (de) Verfahren zur Herstellung von w-Laurinolactam
CH472427A (de) Verfahren zur Herstellung von Antibiotika
AT260209B (de) Verfahren zur Herstellung von Bromalkylbenzolen
CH461476A (de) Verfahren zur Herstellung von Dihydrotricyclopentadienylamin
CH478782A (de) Verfahren zur Herstellung von 13-Alkylgonadienen
CH474479A (de) Verfahren zur Herstellung von Aminopropionyl-o-toluididen
CH463490A (de) Verfahren zur Herstellung von Fluoren-9-olen
CH473129A (de) Verfahren zur Herstellung von Sulfanilamido-Chinazolinen
AT273064B (de) Verfahren zur Herstellung von Adamantan-2-on
CH473091A (de) Verfahren zur Herstellung von Benzhydryloxyacetamiden
AT261571B (de) Verfahren zur Herstellung von α-Amino-ω-lactamen
CH477389A (de) Verfahren zur Herstellung von 7-Oxobenzonorbornenen
CH477396A (de) Verfahren zur Herstellung von Phenyl-propylaminen
CH450423A (de) Verfahren zur Herstellung von 3-Hydroxy-5-aminomethyl-isoxazol